SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-18-011309
Filing Date
2018-08-16
Accepted
2018-08-17 09:23:50
Documents
6
Effectiveness Date
2018-08-16

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs82018_adialpharmaceuticals.htm S-8 74239
2 ADIAL PHARMACEUTICALS, INC. 2017 EQUITY INCENTIVE STOCK PLAN fs82018ex4-1_adialpharma.htm EX-4.1 140552
3 OPINION OF GRACIN & MARLOW, LLP REGARDING LEGALITY OF SHARES fs82018ex5-1_adialpharma.htm EX-5.1 6949
4 CONSENT OF FRIEDMAN LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM fs82018ex23-1_adialpharma.htm EX-23.1 2590
5 GRAPHIC ex5-1img001.jpg GRAPHIC 16673
6 GRAPHIC image_001.jpg GRAPHIC 9490
  Complete submission text file 0001213900-18-011309.txt   261877
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-226884 | Film No.: 181024857
SIC: 2834 Pharmaceutical Preparations